reported that resveratrol attenuates cerebral ischemia‒reperfusion injury by activating the AMPK-Mfn1 pathway and that Mfn1 knockdown abolishes the beneficial effects of resveratrol on hypoxia-reoxygenation (HR)-treated N2a cells (Gao et al. 2019). Here, MFN1 is linked to brain ischemia.